Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
60.951,21
-0,81%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Shield Therapeutics Plc (STX) Shield Therapeutics Plc (STX) Notizie

STX

Shield Therapeutics (STX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:STX
DataOraFonteTitoloSimboloCompagnia
10/05/202416:30RNS Regulatory NewsShield Therapeutics PLC Audited results for the year ended 31 Dec 2023LSE:STXShield Therapeutics Plc
30/04/202420:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Software Circle & Beximco report higher revenueLSE:STXShield Therapeutics Plc
30/04/202408:00RNS Regulatory NewsShield Therapeutics PLC Business Update for Q1 2024LSE:STXShield Therapeutics Plc
16/04/202408:00RNS Regulatory NewsShield Therapeutics PLC Notice of ResultsLSE:STXShield Therapeutics Plc
21/02/202413:36Alliance NewsAlliance NewsShield Therapeutics sinks as strong performance marred by data issuesLSE:STXShield Therapeutics Plc
21/02/202408:00RNS Regulatory NewsShield Therapeutics PLC Unaudited Full Year Trading UpdateLSE:STXShield Therapeutics Plc
09/01/202412:33Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics hires former Akili leader as new CFOLSE:STXShield Therapeutics Plc
09/01/202408:00UK RegulatoryShield Therapeutics PLC Appointment of new Chief Financial OfficerLSE:STXShield Therapeutics Plc
07/12/202316:31Alliance NewsAlliance NewsTRADING UPDATES: Comptoir opens restaurant; Intercede wins contractLSE:STXShield Therapeutics Plc
07/12/202308:00UK RegulatoryShield Therapeutics PLC Q3 2023 U.S. Commercial HighlightsLSE:STXShield Therapeutics Plc
27/11/202318:24UK RegulatoryShield Therapeutics PLC PDMR Transaction NotificationLSE:STXShield Therapeutics Plc
20/10/202312:45RNS Non-RegulatoryShield Therapeutics PLC Abstract to be presented at Healthcare ConferenceLSE:STXShield Therapeutics Plc
12/10/202312:14Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf to leaveLSE:STXShield Therapeutics Plc
12/10/202308:00UK RegulatoryShield Therapeutics PLC Chief Financial Officer TransitionLSE:STXShield Therapeutics Plc
03/10/202318:14Alliance NewsAlliance NewsTRADING UPDATES: Aston Martin CEO ups stake; Alkemy's lithium dealLSE:STXShield Therapeutics Plc
03/10/202316:00UK RegulatoryShield Therapeutics PLC Result of REX Retail OfferLSE:STXShield Therapeutics Plc
03/10/202315:29Alliance NewsAlliance NewsShield Therapeutics completes USD20 million SWK financingLSE:STXShield Therapeutics Plc
03/10/202308:00UK RegulatoryShield Therapeutics PLC Block listing Interim ReturnLSE:STXShield Therapeutics Plc
03/10/202308:00UK RegulatoryShield Therapeutics PLC Completion of SWK FinancingLSE:STXShield Therapeutics Plc
28/09/202315:54Alliance NewsAlliance NewsUPDATE: Shield Therapeutics completes GBP5 million share placingLSE:STXShield Therapeutics Plc
28/09/202313:50UK RegulatoryShield Therapeutics PLC Successful completion of US$6.1m Equity FundraiseLSE:STXShield Therapeutics Plc
28/09/202312:30Alliance NewsAlliance NewsShield Therapeutics raises funds for US sales push as loss narrowsLSE:STXShield Therapeutics Plc
28/09/202308:02UK RegulatoryShield Therapeutics PLC REX Retail OfferLSE:STXShield Therapeutics Plc
28/09/202308:01UK RegulatoryShield Therapeutics PLC $20m secured debt facility &proposed equity raiseLSE:STXShield Therapeutics Plc
28/09/202308:00UK RegulatoryShield Therapeutics PLC Interim results update and business updateLSE:STXShield Therapeutics Plc
06/09/202321:33Alliance NewsAlliance NewsIN BRIEF: Shield Therapeutics changes reporting currency to US dollarsLSE:STXShield Therapeutics Plc
06/09/202308:00UK RegulatoryShield Therapeutics PLC Notice of Results and Change in reporting currencyLSE:STXShield Therapeutics Plc
06/08/202318:07Alliance NewsAlliance NewsCORRECT: Biogens, Sage Therapeutics postpartum depression drug okayedLSE:STXShield Therapeutics Plc
06/08/202315:17Alliance NewsAlliance NewsBiogens, Sage Therapeutics postpartum depression treatment approvedLSE:STXShield Therapeutics Plc
24/07/202315:27UK RegulatoryShield Therapeutics PLC Holding(s) in CompanyLSE:STXShield Therapeutics Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:STX

La tua Cronologia

BIT
ENEL
Enel
BIT
UCG
Unicredit
BIT
BFF
BFF Bank
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
IVG
Iveco Group NV
BIT
RACE
Ferrari NV
BIT
STLAM
Stellantis NV
BIT
ENI
Eni
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
NEXI
Nexi S.p.A
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
MB
Mediobanca Banca di Cred...
BIT
PRY
Prysmian
BIT
STMMI
ST Microelectronics
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network